Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829283 · ClinicalTrials.gov registry record · NA
Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 191
- Enrollment target
NCT00829283: Completed NA study, sponsored by Yale University.
NCT00829283 is a NA study that has completed, run by Yale University. The registered enrollment target is 191 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00829283, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 191 participants
- Enrollment target
Study Summary
This controlled study will test the effectiveness of a stepped-care approach to a standard behavioral weight loss treatment for obese patients with Binge Eating Disorder (BED). The major question is whether the stepped-care approach, which begins with behavioral weight loss and then follows a decision tree for additional interventions based on early treatment response is superior to standard behavioral treatment.
Primary Outcome
Binge Remission (abstinence from binge eating)
Interventions
- DRUG Placebo
- BEHAVIORAL Behavioral Weight Loss
- BEHAVIORAL Behavioral Weight Loss + Guided self-help Cognitive-behavioral Therapy
- DRUG Sibutramine/Orlistat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2008-11 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT00829283 record still lists
NCT00829283 is an interventional study that assigns participants to a tested intervention. The registered 191 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00829283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00829283 about?
NCT00829283 is a clinical study titled "Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care". This controlled study will test the effectiveness of a stepped-care approach to a standard behavioral weight loss treatment for obese patients with Binge Eating Disorder (BED). The major question is whether the stepped-care approach, which begins with behavioral weight loss and then follows a decisi...
What is the current status of trial NCT00829283?
This trial is currently completed. It is a NA study. The enrollment target is 191 participants. The study started on 2008-11. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00829283?
The interventions under investigation include: Placebo (DRUG), Behavioral Weight Loss (BEHAVIORAL), Behavioral Weight Loss + Guided self-help Cognitive-behavioral Therapy (BEHAVIORAL), Sibutramine/Orlistat (DRUG).
Who is sponsoring clinical trial NCT00829283?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00829283's enrollment target sits among peer trials
191 574th of 2000 higher than 1,427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04621435 · 191 participants · Phase 1
Imaging of Solid Tumors Using FAP-2286
- NCT06810544 · 191 participants · Phase 1
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia